Systemic risk governance for pharmaceutical residues in drinking water
Research output: Journal contributions › Scientific review articles › Research
Standard
Systemic risk governance for pharmaceutical residues in drinking water. / Keil, Florian; Bechmann, Gotthard; Kümmerer, Klaus et al.
In: GAIA, Vol. 17, No. 4, 2008, p. 355-361.Research output: Journal contributions › Scientific review articles › Research
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Systemic risk governance for pharmaceutical residues in drinking water
AU - Keil, Florian
AU - Bechmann, Gotthard
AU - Kümmerer, Klaus
AU - Schramm, Engelbert
PY - 2008
Y1 - 2008
N2 - Pharmaceuticals are in many cases an indispensable element ofa comfortable and healthy life. Nevertheless, there is also a downsideto the widespread and increasing use of drugs: the occurrenceof their residues in the aquatic environment and in drinking water.Although there is evidence for negative effects of active pharmaceuticalingredients (APIs) in some animal and plant species, it hasnot yet been shown which risks in fact exist for humans and theenvironment. At the same time there is evidence that people willreject drinking water which contains only the smallest traces of APIs,despite claims that such traces are harmless. In this mélange ofhigh uncertainties, subjective risk perception, and the undisputedsocietal benefit of pharmaceuticals, established risk managementprocedures are likely to fail. Addressing this issue, the article willsuggest applying the concept of systemic risk to the case of APIsin drinking water. With this concept as basis a practical approachto risk management will be presented. It draws upon the recentlydeveloped concept of risk governance, as well as the precautionaryprinciple. Finally, concrete measures for risk precaution in thespheres of drug development, handling of drugs, and technicalemissions control in urban water management will be presented
AB - Pharmaceuticals are in many cases an indispensable element ofa comfortable and healthy life. Nevertheless, there is also a downsideto the widespread and increasing use of drugs: the occurrenceof their residues in the aquatic environment and in drinking water.Although there is evidence for negative effects of active pharmaceuticalingredients (APIs) in some animal and plant species, it hasnot yet been shown which risks in fact exist for humans and theenvironment. At the same time there is evidence that people willreject drinking water which contains only the smallest traces of APIs,despite claims that such traces are harmless. In this mélange ofhigh uncertainties, subjective risk perception, and the undisputedsocietal benefit of pharmaceuticals, established risk managementprocedures are likely to fail. Addressing this issue, the article willsuggest applying the concept of systemic risk to the case of APIsin drinking water. With this concept as basis a practical approachto risk management will be presented. It draws upon the recentlydeveloped concept of risk governance, as well as the precautionaryprinciple. Finally, concrete measures for risk precaution in thespheres of drug development, handling of drugs, and technicalemissions control in urban water management will be presented
KW - Chemistry
KW - drinking water
KW - drug development
KW - health-care system
KW - Pharmaceutical
KW - precautionary principle
KW - risk governance
KW - symtemic risk
KW - urban water management
UR - http://www.scopus.com/inward/record.url?scp=57849086772&partnerID=8YFLogxK
U2 - 10.14512/gaia.17.4.10
DO - 10.14512/gaia.17.4.10
M3 - Scientific review articles
VL - 17
SP - 355
EP - 361
JO - GAIA
JF - GAIA
SN - 0940-5550
IS - 4
ER -